BNBX logo

BNBX
Applied Dna Sciences Inc

22,693
Mkt Cap
$4.42M
Volume
195,910.00
52W High
$35.85
52W Low
$0.6053
PE Ratio
0.00
BNBX Fundamentals
Price
$0.77
Prev Close
$0.8111
Open
$0.7978
50D MA
$1.05
Beta
0.85
Avg. Volume
97,720.51
EPS (Annual)
-$134.23
P/B
0.21
Rev/Employee
$82,189.81
$0.171
Loading...
Loading...
News
all
press releases
BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea IVT Platform
BNB Plus Corp. (Nasdaq: BNBX) ('BNBX' or the 'Company'), announced today that its biopharmaceutical subsidiary, LineaRx, Inc. ('LineaRx'), has been granted a European patent by the European Patent...
Business Wire·5d ago
News Placeholder
More News
News Placeholder
BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA from Genetic Medicine Developers
BNB Plus Corp. (Nasdaq: BNBX) ('BNBX' or the 'Company') today announced that its biopharmaceutical subsidiary, LineaRx, Inc. ('LineaRx'), has received two new orders for LineaDNA from...
Business Wire·27d ago
News Placeholder
BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director
BNB Plus Corp. (Nasdaq: BNBX) ('BNBX' or the 'Company'), today announced the appointment of James Haft as an Independent Director and member of the Boards Nominating Committee, effective as of...
Business Wire·2mo ago
News Placeholder
BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th
BNB Plus Corp. (Nasdaq: BNBX) ('BNBX' or the 'Company'), today announced that Chief Investment Officer Patrick Horsman, CFA and Chairman of the Board Joshua Kruger will present live at the Digital...
Business Wire·2mo ago
News Placeholder
BNB Plus Corp. (BNBX) Receives $1.2M Accelerated LineaDNA Order
BNB Plus Corp. (Nasdaq: BNBX) (BNBX or the Company), today announced that it has received a $1.2M USD order for LineaDNA, representing the largest LineaDNA order in Company history. The order is an...
Business Wire·3mo ago
News Placeholder
BNB Plus Provides BNB Treasury and Operational Updates
BNB Plus Corp. (Nasdaq: BNBX) (BNBX or the Company), today provided a corporate update highlighting its recent strategic treasury growth, expected significant narrowing of losses at its LineaRx, Inc...
Business Wire·3mo ago
News Placeholder
Applied DNA Rebrands as BNB Plus Corp., Elects Josh Kruger as Chairman of the Board
Applied DNA Sciences, Inc. (NASDAQ: BNBX) (the Company) today announced that it will change its name to BNB Plus Corp. (BNB Plus), reflecting the Company's commitment to delivering a yield-optimized...
Business Wire·4mo ago
News Placeholder
BNBX Launches Digital Asset Treasury Dashboard and Provides Corporate Update
Applied DNA Sciences, Inc. (NASDAQ: BNBX) ( BNBX or the Company) today announced the launch of BNBX.io, which provides real-time portfolio metrics updating the market on the Companys BNB treasury...
Business Wire·5mo ago
News Placeholder
Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million
Applied DNA Sciences, Inc. (NASDAQ: BNBX) (Applied DNA, BNBX or the Company), a biotechnology company advancing a yield focused BNB digital asset treasury strategy and commercializing nucleic acid...
Business Wire·5mo ago
<
...
1
>

Latest BNBX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.